trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Inflammatory Breast Neoplasms D058922 2 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Visceral Pain D059265 1 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Capsule Opacification D058442 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Hypesthesia D006987 1 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Wessels I et al. Activation of IL-1β and TNFα genes is mediated by the establishment of permissive chromatin structures during monopoiesis. 2013 Immunobiology pmid:23195574
Wunder T et al. Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. 2013 Cancer Gene Ther. pmid:23196273
Oliveira CS et al. HDAC inhibition decreases XIST expression on female IVP bovine blastocysts. 2013 Reproduction pmid:23104973
Lakshmi SV et al. Oxidative stress in coronary artery disease: epigenetic perspective. 2013 Mol. Cell. Biochem. pmid:23160801
Jackson MF et al. Genetic manipulation of myoblasts and a novel primary myosatellite cell culture system: comparing and optimizing approaches. 2013 FEBS J. pmid:23173931
Bianco C et al. Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. 2013 J. Cell. Physiol. pmid:23129342
Luo Y et al. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. 2013 Eur. J. Cancer pmid:23040637
Culley KL et al. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. 2013 Arthritis Rheum. pmid:23575963
Brown CO et al. Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma. 2013 Leuk. Res. pmid:23537707
Gang H et al. Epigenetic regulation of canonical TNFα pathway by HDAC1 determines survival of cardiac myocytes. 2013 Am. J. Physiol. Heart Circ. Physiol. pmid:23585133
Aseem O et al. Cubilin expression is monoallelic and epigenetically augmented via PPARs. 2013 BMC Genomics pmid:23773363
Wang H et al. Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles. 2013 Nat. Neurosci. pmid:23727821
Humphreys KJ et al. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. 2013 Mol. Carcinog. pmid:22308110
Gao B et al. Inhibition of histone deacetylase activity suppresses IFN-γ induction of tripartite motif 22 via CHIP-mediated proteasomal degradation of IRF-1. 2013 J. Immunol. pmid:23729439
Luo B et al. A possible strategy to produce pigs resistant to porcine reproductive and respiratory syndrome virus. 2013 Antiviral Res. pmid:23732571
Tigges J et al. Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. 2013 J. Invest. Dermatol. pmid:22951721
Doñas C et al. Trichostatin A promotes the generation and suppressive functions of regulatory T cells. 2013 Clin. Dev. Immunol. pmid:23737814
Flight MH Behaviour: epigenetically bonded. 2013 Nat. Rev. Neurosci. pmid:23756635
Zhao TC et al. HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1. 2013 PLoS ONE pmid:23762381
Oksenych V et al. Histone methyltransferase DOT1L drives recovery of gene expression after a genotoxic attack. 2013 PLoS Genet. pmid:23861670
BurlibaÅŸa L and Zarnescu O In vivo effects of Trichostatin A - A histone deacetylase inhibitor - On chromatin remodeling during Triturus cristatus spermatogenesis. 2013 Anim. Reprod. Sci. pmid:24100069
Kang KA et al. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity. 2013 Int. J. Oncol. pmid:24100442
Moldrich RX et al. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. 2013 Behav. Brain Res. pmid:24103642
Yamamura A et al. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. 2013 Biochem. Biophys. Res. Commun. pmid:24134849
Wang X et al. Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells. 2013 Mol. Carcinog. pmid:22121107
Wang YJ et al. Histone acetylation in the olfactory bulb of young rats facilitates aversive olfactory learning and synaptic plasticity. 2013 Neuroscience pmid:23262233
Diao JS et al. Histone deacetylase inhibitor reduces hypertrophic scarring in a rabbit ear model. 2013 Plast. Reconstr. Surg. pmid:23806955
Sharma A et al. Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. 2013 Carcinogenesis pmid:23880304
Li Y et al. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. 2013 Mol. Cancer pmid:23379261
Oliveira CS et al. Supplementation with the histone deacetylase inhibitor trichostatin A during in vitro culture of bovine embryos. 2013 Zygote pmid:21867598
Joosten M et al. Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype. 2013 Haematologica pmid:22899583
Frame FM et al. HDAC inhibitor confers radiosensitivity to prostate stem-like cells. 2013 Br. J. Cancer pmid:24220693
Jagirdar K et al. The NR4A2 nuclear receptor is recruited to novel nuclear foci in response to UV irradiation and participates in nucleotide excision repair. 2013 PLoS ONE pmid:24223135
Hu X et al. Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner. 2013 Stem Cells Dev. pmid:22873791
Liu Y et al. Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. 2013 PLoS ONE pmid:24223801
Yan G et al. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. 2013 Mol. Carcinog. pmid:22290509
Feng T et al. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). 2013 Bioorg. Med. Chem. pmid:23820574
Lopez-Atalaya JP et al. Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition. 2013 Nucleic Acids Res. pmid:23821663
Okada T et al. Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. 2013 Cancer Sci. pmid:23829175
Cong P et al. Effects of trichostatin A on histone acetylation and methylation characteristics in early porcine embryos after somatic cell nuclear transfer. 2013 Anim. Sci. J. pmid:23607426
Munro SK et al. Histone deacetylase inhibition by trichostatin A mitigates LPS induced TNFα and IL-10 production in human placental explants. 2013 Placenta pmid:23623485
Hayakawa K et al. Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells. 2013 J. Biol. Chem. pmid:23625921
Neumann F et al. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors. 2013 Cancer Immunol. Immunother. pmid:23619976
Montero-Melendez T et al. Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors. 2013 Cell Death Differ. pmid:23222458
McBrian MA et al. Histone acetylation regulates intracellular pH. 2013 Mol. Cell pmid:23201122
Shi H et al. Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes. 2013 Biochem. Biophys. Res. Commun. pmid:23201405
Hutz JE et al. The multidimensional perturbation value: a single metric to measure similarity and activity of treatments in high-throughput multidimensional screens. 2013 J Biomol Screen pmid:23204073
Nakazawa Y et al. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. 2013 J. Immunother. pmid:23211626
Tavakoli-Yaraki M et al. Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1. 2013 Tumour Biol. pmid:23055198
Koch M et al. Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling. 2013 Biochem. Pharmacol. pmid:23396090